224 related articles for article (PubMed ID: 18678882)
1. Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.
Ikonomovic MD; Abrahamson EE; Uz T; Manev H; Dekosky ST
J Histochem Cytochem; 2008 Dec; 56(12):1065-73. PubMed ID: 18678882
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
4. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease.
Brion JP; Couck AM; Conreur JL
Neurodegeneration; 1995 Mar; 4(1):13-21. PubMed ID: 7600182
[TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
8. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
10. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
Hyman BT; Elvhage TE; Reiter J
Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042
[TBL] [Abstract][Full Text] [Related]
12. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
14. Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi.
Shijo M; Honda H; Suzuki SO; Hamasaki H; Hokama M; Abolhassani N; Nakabeppu Y; Ninomiya T; Kitazono T; Iwaki T
Brain Pathol; 2018 Jan; 28(1):58-71. PubMed ID: 27997051
[TBL] [Abstract][Full Text] [Related]
15. P38 MAP kinase is activated at early stages in Alzheimer's disease brain.
Sun A; Liu M; Nguyen XV; Bing G
Exp Neurol; 2003 Oct; 183(2):394-405. PubMed ID: 14552880
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.
Lee SC; Zhao ML; Hirano A; Dickson DW
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain.
Wilhelmus MM; Grunberg SC; Bol JG; van Dam AM; Hoozemans JJ; Rozemuller AJ; Drukarch B
Brain Pathol; 2009 Oct; 19(4):612-22. PubMed ID: 18673368
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of protein kinase C isozymes in Alzheimer's disease.
Masliah E; Cole G; Shimohama S; Hansen L; DeTeresa R; Terry RD; Saitoh T
J Neurosci; 1990 Jul; 10(7):2113-24. PubMed ID: 2376771
[TBL] [Abstract][Full Text] [Related]
19. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
